<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39371581</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2641-5224</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Hawai'i journal of health &amp; social welfare</Title><ISOAbbreviation>Hawaii J Health Soc Welf</ISOAbbreviation></Journal><ArticleTitle>A Child with COVID-19 Complicated by Rapidly Progressive Severe Organizing Pneumonia: A Case Report.</ArticleTitle><Pagination><StartPage>274</StartPage><EndPage>278</EndPage><MedlinePgn>274-278</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.62547/XGJS9690</ELocationID><Abstract><AbstractText>A 2-year-old boy tested positive for SARS-CoV-2 and, after 30 days of mild-moderate respiratory symptoms, suddenly deteriorated and required extracorporeal membrane oxygenation. Lung biopsy was performed with findings consistent with organizing pneumonia. He received intensive therapy with high-dose methylprednisolone, intravenous immune globulin, rituximab, and plasmapheresis without improvement. He died after 85 days hospitalization. This case highlights unique presentations of COVID-19 and reaffirms the concept that, while rare in Hawai'i, pediatric COVID-19 is an ongoing problem and that severe, even fatal, disease can occur.</AbstractText><CopyrightInformation>©Copyright 2024 by University Health Partners of Hawai‘i (UHP Hawai‘i).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, John A Burns School of Medicine, University of Hawai'i, Honolulu, HI (TL, AD).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dutta</LastName><ForeName>Anirban</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, John A Burns School of Medicine, University of Hawai'i, Honolulu, HI (TL, AD).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purohit</LastName><ForeName>Prashant J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Division of Critical Care, Kapi'olani Medical Center for Women and Children, Honolulu, HI (PJP, AF).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pathology, Kapi'olani Medical Center for Women and Children, Honolulu, HI (KT).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Kara</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Rheumatology, Kapi'olani Medical Center for Women and Children, Honolulu, HI (KY, DK).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Critical Care, Kapi'olani Medical Center for Women and Children, Honolulu, HI (PJP, AF).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaty</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Pulmonary, Kapi'olani Medical Center for Women and Children, Honolulu, HI (TB, BW, EF).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melish</LastName><ForeName>Marian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Diseases, Kapi'olani Medical Center for Women and Children, Honolulu, HI (MM, BP, REB).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prothero</LastName><ForeName>Bryscen</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Infectious Diseases, Kapi'olani Medical Center for Women and Children, Honolulu, HI (MM, BP, REB).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurahara</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Rheumatology, Kapi'olani Medical Center for Women and Children, Honolulu, HI (KY, DK).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Pulmonary, Kapi'olani Medical Center for Women and Children, Honolulu, HI (TB, BW, EF).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fong</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pulmonary, Kapi'olani Medical Center for Women and Children, Honolulu, HI (TB, BW, EF).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bégué</LastName><ForeName>Rodolfo E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Infectious Diseases, Kapi'olani Medical Center for Women and Children, Honolulu, HI (MM, BP, REB).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hawaii J Health Soc Welf</MedlineTA><NlmUniqueID>101750601</NlmUniqueID><ISSNLinking>2641-5216</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber><NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017809" MajorTopicYN="N">Fatal Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006254" MajorTopicYN="N" Type="Geographic">Hawaii</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000092124" MajorTopicYN="N">Organizing Pneumonia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MDA-5</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">complication</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">mortality</Keyword></KeywordList><CoiStatement>None of the authors identify a conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>11</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39371581</ArticleId><ArticleId IdType="pmc">PMC11450319</ArticleId><ArticleId IdType="doi">10.62547/XGJS9690</ArticleId><ArticleId IdType="pii">2641-5224-83-10-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention – CDC  . COVID Data Tracker. Centers for Disease Control and Prevention – CDC; 2024.  Updated April 27, Accessed May 6, 2024,  https://covid.cdc.gov/covid-data-tracker/#datatracker-home.</Citation></Reference><Reference><Citation>State of Hawaii, Department of Health, Disease Outbreak Control Division/COVID-19  . State of Hawaii COVID-19 Data Dashboards. State of Hawaii, Department of Health, Disease Outbreak Control Division/COVID-19; 2024.  Updated May 1, Accessed May 6, 2024.  https://health.hawaii.gov/coronavirusdisease2019.</Citation></Reference><Reference><Citation>Woodruff RC, Campbell AP, Taylor CA, et al. Risk factors for severe COVID-19 in children. Pediatrics. 2022;149(1):e2021053418. doi: 10.1542/peds.2021-053418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-053418</ArticleId><ArticleId IdType="pmc">PMC9213563</ArticleId><ArticleId IdType="pubmed">34935038</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, Burrows EK, Mejias A, et al. Severity of Acute COVID-19 in Children &lt;18 Years Old March 2020 to December 2021. Pediatrics. 2022;149(4):e2021055765. doi: 10.1542/peds.2021-055765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-055765</ArticleId><ArticleId IdType="pubmed">35322270</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Dambrauskas S, Vasquez-Hoyos P, Camporesi A, et al. Paediatric critical COVID-19 and mortality in a multinational prospective cohort. Lancet Reg Health Am. 2022;12:100272. doi: 10.1016/j.lana.2022.100272. Aug;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2022.100272</ArticleId><ArticleId IdType="pmc">PMC9111167</ArticleId><ArticleId IdType="pubmed">35599855</ArticleId></ArticleIdList></Reference><Reference><Citation>Baque-Juston M, Pellegrin A, Leroy S, Marquette CH, Padovani B. Organizing pneumonia: what is it? A conceptual approach and pictorial review. Diagn Interv Imaging. 2014;95(9):771–777. doi: 10.1016/j.diii.2014.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diii.2014.01.004</ArticleId><ArticleId IdType="pubmed">24559802</ArticleId></ArticleIdList></Reference><Reference><Citation>Khrais A, Smighelschi B, Zainab M. Legionella: Organizing Pneumonia vs Persistent Infection. Cureus. 2022;14(9):e29685. doi: 10.7759/cureus.29685.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.29685</ArticleId><ArticleId IdType="pmc">PMC9615346</ArticleId><ArticleId IdType="pubmed">36321027</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeidan BS, Jr, Patel JK, Kirk A, Gonzalez A, Khan I. Cryptogenic Organizing Pneumonia Secondary to Mycoplasma pneumoniae Infection: A Case Report. Cureus. 2021;13(12):e20623. doi: 10.7759/cureus.20623.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.20623</ArticleId><ArticleId IdType="pmc">PMC8786583</ArticleId><ArticleId IdType="pubmed">35106194</ArticleId></ArticleIdList></Reference><Reference><Citation>Asai N, Yokoi T, Nishiyama N, et al. Secondary organizing pneumonia following viral pneumonia caused by severe influenza B: a case report and literature reviews. BMC Infect Dis. 2017;17(1):572. doi: 10.1186/s12879-017-2677-1..</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2677-1.</ArticleId><ArticleId IdType="pmc">PMC5558726</ArticleId><ArticleId IdType="pubmed">28810835</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon HS, Lee EJ, Lee JY, Chon GR, Lee SH, Kim SJ. Organizing pneumonia associated with Mycobacterium tuberculosis infection. Respirol Case Rep. 2015;3(4):128–131. doi: 10.1002/rcr2.135..</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcr2.135.</ArticleId><ArticleId IdType="pmc">PMC4694599</ArticleId><ArticleId IdType="pubmed">26835126</ArticleId></ArticleIdList></Reference><Reference><Citation>Vadász I, Husain-Syed F, Dorfmüller P, et al. Severe organising pneumonia following COVID-19. Thorax. 2021;76(2):201–204. doi: 10.1136/thoraxjnl-2020-216088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216088</ArticleId><ArticleId IdType="pubmed">33177230</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong WH, Saha BK, Chopra A. Does COVID-19 pneumonia signify secondary organizing pneumonia?: A narrative review comparing the similarities between these two distinct entities. Heart Lung. 2021;50(5):667–674. doi: 10.1016/j.hrtlng.2021.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2021.04.009</ArticleId><ArticleId IdType="pmc">PMC8164344</ArticleId><ArticleId IdType="pubmed">34098237</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond D, Thumerelle C, Roux A, et al. Severe COVID-19 evolving towards organizing pneumonia in a pediatric lung transplant recipient. Pediatr Pulmonol. 2022;57(2):583–585. doi: 10.1002/ppul.25744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25744</ArticleId><ArticleId IdType="pmc">PMC8662090</ArticleId><ArticleId IdType="pubmed">34727580</ArticleId></ArticleIdList></Reference><Reference><Citation>Merdji H, Mayeur S, Schenck M, et al. Histopathological features in fatal COVID-19 acute respiratory distress syndrome. Med Intensiva. 2021;45(5):261–270. doi: 10.1016/j.medine.2021.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medine.2021.02.005</ArticleId><ArticleId IdType="pmc">PMC8161799</ArticleId><ArticleId IdType="pubmed">34059216</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Guo L, Fu Y, et al. Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis. Clin Rev Allergy Immunol. 2021;60(2):293–304. doi: 10.1007/s12016-020-08822-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-020-08822-5</ArticleId><ArticleId IdType="pubmed">33405101</ArticleId></ArticleIdList></Reference><Reference><Citation>González-Moreno J, Raya-Cruz M, Losada-Lopez I, Cacheda AP, Oliver C, Colom B. Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review. Rheumatol Int. 2018;38(7):1293–1296. doi: 10.1007/s00296-018-3991-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-018-3991-7</ArticleId><ArticleId IdType="pmc">PMC7101732</ArticleId><ArticleId IdType="pubmed">29417209</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonutti A, Motta F, Ceribelli A, Isailovic N, Selmi C, De Santis M. Anti-MDA5 antibody linking COVID-19, Type I interferon, and autoimmunity: A case report and systematic literature review. Front Immunol. 2022;13:937667. doi: 10.3389/fimmu.2022.937667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.937667</ArticleId><ArticleId IdType="pmc">PMC9271786</ArticleId><ArticleId IdType="pubmed">35833112</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol. 2022;94(1):54–62. doi: 10.1002/jmv.27292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27292</ArticleId><ArticleId IdType="pmc">PMC8661629</ArticleId><ArticleId IdType="pubmed">34427929</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Tenforde MW, Friedman KG, et al. Overcoming COVID-19 investigators. characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA. 2021;325(11):1074–1087. doi: 10.1001/jama.2021.2091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.2091</ArticleId><ArticleId IdType="pmc">PMC7905703</ArticleId><ArticleId IdType="pubmed">33625505</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>